Karl Swedberg

Seniorprofessor

Institutionen för

medicin

E-post

karl.swedberg@gu.se

Besöksadress

Wallenberglab/su

Göteborg

Rumsnummer

1319

Postadress

SU Sahlgrenska

413 45 Göteborg

Seniorforskare

Avd för molekylär och klinisk

medicin

E-post

karl.swedberg@gu.se

Om Karl Swedberg

Karl Swedberg är seniorprofessor i kardiologi och vårdvetenskap och överläkare vid medicinkliniken, Sahlgrenska Universitetssjukhuset/Östra, är vetenskaplig rådgivare vid Centrum för Person-Centrerad Vård vid Göteborgs Universitet (GPCC).

Utmärkelser

Hedersmedlem i Svenska Kardiologföreningen
Kaufmann Award on heart failure research från Cleveland Clinics, USA 2004
Europeiska Kardiologföreningens (ESC) guldmedalj 2007 för ”outstanding” klinisk forskning
Han höll Paul Dudley White International Lecture at AHA 2009.
"Life-time Achievement Award" från Heart Failure Association (HFA) inom ESC 2016.
Han har varit Editor-in-Chief European Journal of Heart Failure 2005-2009.
Sedan 2012 är han Associate Editor, European Heart Journal (IF 23)
Bland mest citerade 2017-2019

Läs mer om Karl Swedberg och hans forskning här (på engelska).

Publikationer

Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF
trial

P. Tolomeo, J. H. Butt, T. Kondo, G. Campo, A. S. Desai, P. S. Jhund, L. Kober, M. P. Lefkowitz, J. L. Rouleau, S. D. Solomon, Karl Swedberg, M. Vaduganathan, M. R. Zile, M. Packer, J. J. V. McMurray
European Heart Journal - 2023
Prevalent and Incident Anemia in PARADIGM-HF and the Effect of
Sacubitril/Valsartan

J. P. Curtain, C. Adamson, K. F. Docherty, P. S. Jhund, A. S. Desai, M. P. Lefkowitz, A. R. Rizkala, J. L. Rouleau, Karl Swedberg, M. R. Zile, S. D. Solomon, M. Packer, J. J. V. McMurray
Jacc-Heart Failure - 2023
Efficacy of ivabradine in heart failure patients with a high-risk profile (analysis from the SHIFT
trial)

A. Abdin, M. Komajda, J. S. Borer, I. Ford, L. Tavazzi, C. Batailler, Karl Swedberg, G. M. C. Rosano, F. Mahfoud, M. Bohm
Esc Heart Failure - 2023
Incremental prognostic value of biomarkers in
PARADIGM-HF

K. McDowell, R. Campbell, J. Simpson, J. W. Cunningham, A. S. Desai, P. S. Jhund, M. P. Lefkowitz, J. L. Rouleau, Karl Swedberg, M. R. Zile, S. D. Solomon, M. Packer, J. J. V. McMurray
European Journal of Heart Failure - 2023
Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection
fraction

M. Bohm, A. Abdin, J. Slawik, F. Mahfoud, J. Borer, I. Ford, Karl Swedberg, L. Tavazzi, C. Batailler, M. Komajda
European Journal of Heart Failure - 2023
Associations Between New York Heart Association Classification, Objective Measures, and Long-term Prognosis in Mild Heart Failure A Secondary Analysis of the PARADIGM-HF
Trial

L. E. Rohde, A. Zimerman, M. Vaduganathan, B. L. Claggett, M. Packer, A. S. Desai, M. Zile, J. Rouleau, Karl Swedberg, M. Lefkowitz, V. C. Shi, J. J. V. McMurray, S. D. Solomon
Jama Cardiology - 2023
Time to clinical benefit of eplerenone among patients with heart failure and reduced ejection fraction: a subgroups analysis from the EMPHASIS-HF
trial

L. Monzo, N. Girerd, K. Duarte, J. P. Ferreira, J. J. V. McMurray, D. J. van Veldhuisen, Karl Swedberg, S. J. Pocock, B. Pitt, F. Zannad
European Journal of Heart Failure - 2023
Impact of multimorbidity on mortality in heart failure with reduced ejection fraction: which comorbidities matter most? An analysis of PARADIGM-HF and
ATMOSPHERE

Pooja Dewan, João Pedro Ferreira, Jawad H. Butt, Mark C. Petrie, William T. Abraham, Akshay S. Desai, Kenneth Dickstein, Lars Køber, Milton Packer, Jean L. Rouleau, Simon Stewart, Karl Swedberg, Michael R. Zile, Scott D. Solomon, Pardeep S. Jhund, John J.V. McMurray
European Journal of Heart Failure - 2023
Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity
paradox

J. H. Butt, M. C. Petrie, P. S. Jhund, N. Sattar, A. S. Desai, L. Kober, J. L. Rouleau, Karl Swedberg, M. R. Zile, S. D. Solomon, M. Packer, J. J. V. McMurray
European Heart Journal - 2023
Integrating Health Promotion with and for Older People - eHealth (IHOPe) – Evaluating remote integrated person-centred care - Protocol of a randomised controlled trial with effectiveness, health economic, and process
evaluation

Zahra Ebrahimi, Emmelie Barenfeld, Hanna Gyllensten, Patricia Olaya-Contreras, Andreas Fors, Eva Fredholm, Joanne M. Fuller, Mahboubeh Goudarzi, Birgitta Krantz, Karl Swedberg, Inger Ekman
BMC Geriatrics - 2023
Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in
PARADIGM-HF

J. P. Curtain, A. M. Jackson, L. Shen, P. S. Jhund, K. F. Docherty, M. C. Petrie, D. Castagno, A. S. Desai, L. E. Rohde, M. P. Lefkowitz, J. L. Rouleau, M. R. Zile, S. D. Solomon, Karl Swedberg, M. Packer, J. J. V. McMurray
European Journal of Heart Failure - 2022
Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from
RED-HF

T. Ueland, L. Gullestad, L. Kou, J. B. Young, M. A. Pfeffer, D. J. van Veldhuisen, Karl Swedberg, J. J. V. McMurray, A. S. Desai, I. S. Anand, P. Aukrust
Clinical Research in Cardiology - 2022
Effects of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EMPHASIS-HF and
RALES

S. E. Yeoh, P. Dewan, M. Serenelli, J. P. Ferreira, B. Pitt, Karl Swedberg, D. J. van Veldhuisen, F. Zannad, P. S. Jhund, J. J. V. McMurray
European Journal of Heart Failure - 2022
Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF
trials

M. O. Wijkman, B. Claggett, M. Vaduganathan, J. W. Cunningham, R. Rorth, A. Jackson, M. Packer, M. Zile, J. Rouleau, Karl Swedberg, M. Lefkowitz, S. J. Shah, M. A. Pfeffer, J. J. V. McMurray, S. D. Solomon
Cardiovascular Diabetology - 2022
Person-Centred Care, Theory, Operationalisation and
Effects

Inger Ekman, Karl Swedberg
Intelligent Systems for Sustainable Person-Centered Healthcare. Dalia Kriksciuniene, Virgilijus Sakalauskas (red.) - 2022
Predicting stroke in heart failure and reduced ejection fraction without atrial
fibrillation

T. Kondo, A. H. Abdul-Rahim, A. Talebi, W. T. Abraham, A. S. Desai, K. Dickstein, S. E. Inzucchi, L. Kober, M. N. Kosiborod, F. A. Martinez, M. Packer, M. Petrie, P. Ponikowski, J. L. Rouleau, M. S. Sabatine, Karl Swedberg, M. R. Zile, S. D. Solomon, P. S. Jhund, J. J. V. McMurray
European Heart Journal - 2022
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney
function.

Hiddo J L Heerspink, David Cherney, Douwe Postmus, Bergur V Stefánsson, Glenn M Chertow, Jamie P Dwyer, Tom Greene, Mikhail Kosiborod, Anna Maria Langkilde, John J V McMurray, Ricardo Correa-Rotter, Peter Rossing, C David Sjöström, Robert D Toto, David C Wheeler, Karl Swedberg
Kidney international - 2022
Angiotensin-neprilysin inhibition and renal outcomes across the spectrum of ejection fraction in heart
failure

F. R. Mc Causland, M. P. Lefkowitz, B. Claggett, M. Packer, M. Senni, M. Gori, P. S. Jhund, M. M. McGrath, J. L. Rouleau, V. Shi, Karl Swedberg, M. Vaduganathan, F. Zannad, M. A. Pfeffer, M. Zile, J. J. V. McMurray, S. D. Solomon
European Journal of Heart Failure - 2022
Clinical Outcomes Related to Background Diuretic Use and New Diuretic Initiation in Patients With
HFrEF

J. P. Curtain, R. T. Campbell, M. C. Petrie, A. M. Jackson, W. T. Abraham, A. S. Desai, K. Dickstein, L. Kober, J. L. Rouleau, Karl Swedberg, M. R. Zile, S. D. Solomon, P. S. Jhund, J. J. V. McMurray
Jacc-Heart Failure - 2022
Effects of a Person-Centered eHealth Intervention for Patients on Sick Leave Due to Common Mental Disorders (PROMISE Study): Open Randomized Controlled
Trial

Matilda Cederberg, Sara Alsén, Lilas Ali, Inger Ekman, K. Glise, Ingibjörg H Jonsdottir, Hanna Gyllensten, Karl Swedberg, Andreas Fors
Jmir Mental Health - 2022
Diuretic therapy as prognostic enrichment factor for clinical trials in patients with heart failure with reduced ejection
fraction

S. Coiro, N. Girerd, J. J. V. McMurray, B. Pitt, Karl Swedberg, D. J. van Veldhuisen, Z. Lamiral, P. Rossignol, F. Zannad
Clinical Research in Cardiology - 2021
Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE
trials

M. S. Khan, S. L. Kristensen, M. Vaduganathan, L. Kober, W. T. Abraham, A. S. Desai, S. D. Solomon, Karl Swedberg, K. Dickstein, M. R. Zile, M. Packer, J. J. V. McMurray, J. Butler
American Heart Journal - 2021
Dynamic changes in cardiovascular and systemic parameters prior to sudden cardiac death in heart failure with reduced ejection fraction: a PARADIGM-HF
analysis

L. E. Rohde, M. Vaduganathan, B. L. Claggett, C. A. Polanczyk, P. Dorbala, M. Packer, A. S. Desai, M. Zile, J. Rouleau, Karl Swedberg, M. Lefkowitz, V. Shi, J. J. V. McMurray, S. D. Solomon
European Journal of Heart Failure - 2021
Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and
ATMOSPHERE

L. Shen, B. L. Claggett, P. S. Jhund, W. T. Abraham, A. S. Desai, K. Dickstein, J. J. Gong, L. V. Kober, M. P. Lefkowitz, J. L. Rouleau, V. C. Shi, Karl Swedberg, M. R. Zile, S. D. Solomon, J. J. V. McMurray
Clinical Research in Cardiology - 2021
Implementation of Person-Centered Care: A Feasibility Study Using the WE-CARE
Roadmap

R. A. Lewandowski, J. B. Lewandowski, Inger Ekman, Karl Swedberg, Jan Törnell, H. L. Rogers
International Journal of Environmental Research and Public Health - 2021
Testing cost containment of future healthcare with maintained or improved quality—The COSTCARES
project

Karl Swedberg, Desmond Cawley, Inger Ekman, Heather L. Rogers, Darijana Antonic, Daiga Behmane, Ida Björkman, Nicky Britten, Sandra C. Buttigieg, Vivienne Byers, Mats Börjesson, Kirsten Corazzini, Andreas Fors, Bradi Granger, Boban Joksimoski, Roman Lewandowski, Virgilijus Sakalauskas, Einav Srulovici, Jan Törnell, Sara Wallström, Axel Wolf, Helen M. Lloyd
Health Science Reports - 2021
Effects of person-centred care using digital platform and structured telephone support for people with chronic obstructive pulmonary disease and chronic heart failure: Randomized controlled
trial

Lilas Ali, Sara Wallström, Andreas Fors, Emmelie Barenfeld, Eva Fredholm, Michael Fu, Mahboubeh Goudarzi, Hanna Gyllensten, Irma Lindström Kjellberg, Karl Swedberg, Lowie E G W Vanfleteren, Inger Ekman
Journal of Medical Internet Research - 2021
Stimulation of contractility in systolic heart
failure

Karl Swedberg
New England Journal of Medicine - 2021
The clinical practice of treating patients with chronic heart failure needs to be
improved

Karl Swedberg
European Journal of Heart Failure - 2021
Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM-HF
trial

A. S. Bhatt, M. Vaduganathan, B. L. Claggett, J. K. Liu, M. Packer, A. S. Desai, M. P. Lefkowitz, J. L. Rouleau, V. C. Shi, M. R. Zile, Karl Swedberg, O. Vardeny, J. J. V. McMurray, S. D. Solomon
European Journal of Heart Failure - 2021
Incidence and Outcomes of Pneumonia in Patients With Heart
Failure

L. Shen, P. S. Jhund, I. S. Anand, A. S. Bhatt, A. S. Desai, A. P. Maggioni, F. A. Martinez, M. A. Pfeffer, A. R. Rizkala, J. L. Rouleau, Karl Swedberg, M. Vaduganathan, O. Vardeny, D. J. van Veldhuisen, F. Zannad, M. R. Zile, M. Packer, S. D. Solomon, J. J. V. McMurray
Journal of the American College of Cardiology - 2021
Heart failure subtypes: Pathophysiology and
definitions

Karl Swedberg
Diabetes Research and Clinical Practice - 2021
Impact of Insulin Treatment on the Effect of Eplerenone: Insights From the EMPHASIS-HF
Trial

J. P. Ferreira, Z. Lamiral, J. J. V. McMurray, Karl Swedberg, D. J. van Veldhuisen, J. Vincent, P. Rossignol, S. J. Pocock, B. Pitt, F. Zannad
Circulation-Heart Failure - 2021
Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection
fraction

L. Shen, P. S. Jhund, I. S. Anand, P. E. Carson, A. S. Desai, C. B. Granger, L. Kober, M. Komajda, R. S. McKelvie, M. A. Pfeffer, S. D. Solomon, Karl Swedberg, M. R. Zile, J. J. V. McMurray
Clinical Research in Cardiology - 2021
Effects of person-centred care via telephone on self-efficacy in patients with chronic obstructive pulmonary disease: Subgroup analysis of a randomized controlled
trial

Lilas Ali, Sara Wallström, Inger Ekman, Karl Swedberg, Andreas Fors
Nursing Open - 2021
Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan Insights From a Combined PARAGON-HF and PARADIGM-HF
Analysis

L. E. Rohde, B. L. Claggett, E. Wolsk, M. Packer, M. Zile, Karl Swedberg, J. Rouleau, M. A. Pfeffer, A. S. Desai, L. H. Lund, L. Kober, I. Anand, B. Merkely, M. Senni, V. Shi, A. Rizkala, M. Lefkowitz, J. J. V. McMurray, S. D. Solomon
Circulation-Heart Failure - 2021
Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From
PARADIGM-HF

S. Ehteshami-Afshar, L. Mooney, P. Dewan, A. S. Desai, N. N. Lang, M. P. Lefkowitz, M. C. Petrie, A. R. Rizkala, J. L. Rouleau, S. D. Solomon, Karl Swedberg, V. C. Shi, M. R. Zile, M. Packer, J. J. V. McMurray, P. S. Jhund, N. M. Hawkins
Journal of the American Heart Association - 2021
Relationship between duration of heart failure, patient characteristics, outcomes, and effect of therapy in
PARADIGM-HF

S. E. Yeoh, P. Dewan, A. S. Desai, S. D. Solomon, J. L. Rouleau, M. Lefkowitz, A. Rizkala, Karl Swedberg, M. R. Zile, P. S. Jhund, M. Packer, J. J. V. McMurray
Esc Heart Failure - 2020
Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause: A PARADIGM-HF
Analysis

L. E. Rohde, N. A. Chatterjee, M. Vaduganathan, B. Claggett, M. Packer, A. S. Desai, M. Zile, J. Rouleau, Karl Swedberg, M. Lefkowitz, V. Shi, J. J. McMurray, S. D. Solomon
Jacc-Heart Failure - 2020
Person-centred eHealth intervention for patients on sick leave due to common mental disorders: study protocol of a randomised controlled trial and process evaluation
(PROMISE)

Matilda Cederberg, Lilas Ali, Inger Ekman, K. Glise, Ingibjörg H Jonsdottir, Hanna Gyllensten, Karl Swedberg, Andreas Fors
BMJ Open - 2020
Myocardial Infarction in Heart Failure With Preserved Ejection Fraction Pooled Analysis of 3 Clinical
Trials

J. W. Cunningham, M. Vaduganathan, B. L. Claggett, J. E. John, A. S. Desai, E. F. Lewis, M. R. Zile, P. Carson, P. S. Jhund, L. Kober, B. Pitt, S. J. Shah, Karl Swedberg, I. S. Anand, S. Yusuf, J. J. V. McMurray, M. A. Pfeffer, S. D. Solomon
Jacc-Heart Failure - 2020
The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and
ATMOSPHERE

P. Dewan, A. Jackson, P. S. Jhund, L. Shen, J. P. Ferreira, M. C. Petrie, W. T. Abraham, A. S. Desai, K. Dickstein, L. Kober, M. Packer, J. L. Rouleau, S. D. Solomon, Karl Swedberg, M. R. Zile, J. J. V. McMurray
European Journal of Heart Failure - 2020
Dumping adherence: a person-centred response for primary
care

B. B. Granger, Nicky Britten, Karl Swedberg, Inger Ekman
Family Practice - 2020
Prevalence and incidence of intraventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: Insights from PARADIGM-HF and
ATMOSPHERE

S. L. Kristensen, D. Castagno, L. Shen, P. Jhund, K. Docherty, R. Rorth, W. T. Abraham, A. Desai, K. Dickstein, J. L. Rouleau, M. R. Zile, Karl Swedberg, M. Packer, S. D. Solomon, L. Kober, J. J. McMurray, H. F. Paradigm
European Journal of Heart Failure - 2020
Effect of growth hormone treatment on circulating levels of NT-proBNP in patients with ischemic heart
failure.

Kristjan Karason, Emanuele Bobbio, Christian Lars Polte, Entela Bollano, Magnus Peterson, Antonio Cittadini, Kenneth Caidahl, Åke Hjalmarson, Bengt-Åke Bengtsson, Jan Ekelund, Karl Swedberg, Jörgen Isgaard
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society - 2020
Liver function and prognosis, and influence of sacubitril/valsartan in patients with heart failure with reduced ejection
fraction

K. Suzuki, B. Claggett, M. Minamisawa, M. Packer, M. R. Zile, J. Rouleau, Karl Swedberg, M. Lefkowitz, V. Shi, J. J. V. McMurray, S. D. Zucker, S. D. Solomon
European Journal of Heart Failure - 2020
Cardiovascular risk associated with serum potassium in the context of mineralocorticoid receptor antagonist use in patients with heart failure and left ventricular
dysfunction

P. Rossignol, K. Duarte, N. Girerd, M. Karoui, J. J. V. McMurray, Karl Swedberg, D. J. van Veldhuisen, S. Pocock, K. Dickstein, F. Zannad, B. Pitt
European Journal of Heart Failure - 2020
Effects of a person-centred telephone support on fatigue in people with chronic heart failure: Subgroup analysis of a randomised controlled
trial.

Sara Wallström, Lilas Ali, Inger Ekman, Karl Swedberg, Andreas Fors
European journal of cardiovascular nursing - 2020
Person-centred care by a combined digital platform and structured telephone support for people with chronic obstructive pulmonary disease and/or chronic heart failure: study protocol for the PROTECT randomised controlled
trial

Lilas Ali, Sara Wallström, Emmelie Barenfeld, Andreas Fors, E. Fredholm, Hanna Gyllensten, Karl Swedberg, Inger Ekman
BMJ Open - 2020
Prognostic Models Derived in PARADIGM-HF and Validated in ATMOSPHERE and the Swedish Heart Failure Registry to Predict Mortality and Morbidity in Chronic Heart
Failure

J. Simpson, P. S. Jhund, L. H. Lund, S. Padmanabhan, B. L. Claggett, L. Shen, M. C. Petrie, W. T. Abraham, A. S. Desai, K. Dickstein, L. Køber, M. Packer, J. L. Rouleau, G. Mueller-Velten, S. D. Solomon, Karl Swedberg, M. R. Zile, J. J. V. McMurray
JAMA Cardiology - 2020
Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection
Fraction

R. Rørth, P. S. Jhund, M. B. Yilmaz, S. L. Kristensen, P. Welsh, A. S. Desai, L. Køber, M. F. Prescott, J. L. Rouleau, S. D. Solomon, Karl Swedberg, M. R. Zile, M. Packer, J. J. V. McMurray
Circulation. Heart failure - 2020
Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection
fraction.

Kieran F Docherty, Li Shen, Davide Castagno, Mark C Petrie, William T Abraham, Michael Böhm, Akshay S Desai, Kenneth Dickstein, Lars V Køber, Milton Packer, Jean L Rouleau, Scott D Solomon, Karl Swedberg, Ali Vazir, Michael R Zile, Pardeep S Jhund, John J V McMurray
European journal of heart failure - 2020
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart
Failure.

Scott D Solomon, Muthiah Vaduganathan, Brian L Claggett, Milton Packer, Michael Zile, Karl Swedberg, Jean Rouleau, Marc A Pfeffer, Akshay Desai, Lars H Lund, Lars Koeber, Inder Anand, Nancy K Sweitzer, Gerard Linssen, Bela Merkely, Juan Luis Arango, Dragos Vinereanu, Chen-Huan Chen, Michele Senni, Antonio Sibulo, Sergey Boytsov, Victor Shi, Adel Rizkala, Martin Lefkowitz, John J V McMurray
Circulation - 2020
Visit-to-visit blood pressure variation and outcomes in heart failure with reduced ejection fraction: findings from the Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
trial.

Luca Monzo, João Pedro Ferreira, Paula Abreu, Annette Szumski, Michael Böhm, John J V McMurray, Bertram Pitt, Karl Swedberg, Dirk J van Veldhuisen, Nicolas Girerd, John Vincent, Faiez Zannad, Patrick Rossignol
Journal of hypertension - 2020
Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection
fraction

L. Shen, R. Rorth, D. Cosmi, S. L. Kristensen, M. C. Petrie, F. Cosmi, R. Latini, L. Kober, I. S. Anand, P. E. Carson, C. B. Granger, M. Komajdal, R. S. McKelvie, S. D. Solomon, L. Staszewsky, Karl Swedberg, T. Huynh, M. R. Zile, P. S. Jhund, J. J. V. McMurray
European Journal of Heart Failure - 2019
Income Inequality and Outcomes in Heart Failure A Global Between-Country
Analysis

P. Dewan, R. Rorth, P. S. Jhund, J. P. Ferreira, F. Zannad, L. Shen, L. Kober, W. T. Abraham, A. S. Desai, K. Dickstein, M. Packer, J. L. Rouleau, S. D. Solomon, Karl Swedberg, M. R. Zile, J. J. V. McMurray
Jacc-Heart Failure - 2019
B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan:
The PARADIGM-HF Trial.

Peder Langeland Myhre, Muthiah Vaduganathan, Brian Claggett, Milton Packer, Akshay S Desai, Jean L Rouleau, Michael R Zile, Karl Swedberg, Martin Lefkowitz, Victor Shi, John J V McMurray, Scott D Solomon
Journal of the American College of Cardiology - 2019
Renal function stratified dose comparisons of eplerenone versus placebo in the EMPHASIS-HF
trial

J. P. Ferreira, P. Abreu, J. J. V. McMurray, D. J. van Veldhuisen, Karl Swedberg, S. J. Pocock, J. Vincent, K. Lins, P. Rossignol, B. Pitt, F. Zannad
European Journal of Heart Failure - 2019
Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF
trial

O. Vardeny, B. Claggett, J. Kachadourian, A. S. Desai, M. Packer, J. Rouleau, M. R. Zile, Karl Swedberg, M. Lefkowitz, V. Shi, J. J. V. McMurray, S. D. Solomon
European Journal of Heart Failure - 2019
Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With
HFrEF

M. R. Zile, E. O'Meara, B. Claggett, M. F. Prescott, S. D. Solomon, Karl Swedberg, M. Packer, J. J. V. McMurray, V. Shi, M. Lefkowitz, J. Rouleau
Journal of the American College of Cardiology - 2019
Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart
rate

K. L. Chin, T. Collier, S. Pocock, B. Pitt, J. J. V. McMurray, D. J. van Veldhuisen, Karl Swedberg, J. Vincent, F. Zannad, D. Liew
Clinical Research in Cardiology - 2019
Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the
Americas.

Pooja Dewan, Pardeep S Jhund, Li Shen, Mark C Petrie, William T Abraham, M Atif Ali, Chen-Huan Chen, Akshay S Desai, Kenneth Dickstein, Jun Huang, Songsak Kiatchoosakun, Kee-Sik Kim, Lars Køber, Wen-Ter Lai, Yuhua Liao, Ulrik M Mogensen, Byung-Hee Oh, Milton Packer, Jean L Rouleau, Victor Shi, Antonio S Sibulo, Scott D Solomon, Piyamitr Sritara, Karl Swedberg, Hiroyuki Tsutsui, Michael R Zile, John J V McMurray
European journal of heart failure - 2019
The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without
diabetes

R. Rorth, P. S. Jhund, S. L. Kristensen, A. S. Desai, L. Kober, J. L. Rouleau, S. D. Solomon, Karl Swedberg, M. R. Zile, M. Packer, J. J. V. McMurray
European Journal of Heart Failure - 2019
Person-Centred Care in Patients with Acute Coronary Syndrome: Cost-Effectiveness Analysis Alongside a Randomised Controlled
Trial.

Laura Pirhonen, Kristian Bolin, Elisabeth Hansson-Olofsson, Andreas Fors, Inger Ekman, Karl Swedberg, Hanna Gyllensten
PharmacoEconomics - open - 2019
Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77
b.p.m.

Nadia Bouabdallaoui, Eileen O'Meara, Virginie Bernier, Michel Komajda, Karl Swedberg, Luigi Tavazzi, Jeffrey S Borer, Michael Bohm, Ian Ford, Jean-Claude Tardif
ESC heart failure - 2019
Sex-Related Differences in Heart Failure With Preserved Ejection
Fraction.

Pooja Dewan, Rasmus Rørth, Valeria Raparelli, Ross T Campbell, Li Shen, Pardeep S Jhund, Mark C Petrie, Inder S Anand, Peter E Carson, Akshay S Desai, Christopher B Granger, Lars Køber, Michel Komajda, Robert S McKelvie, Eileen O'Meara, Marc A Pfeffer, Bertram Pitt, Scott D Solomon, Karl Swedberg, Michael R Zile, John J V McMurray
Circulation. Heart failure - 2019
Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction
PARADIGM-HF

S. Selvaraj, B. Claggett, A. Pozzi, J. J. V. McMurray, P. S. Jhund, M. Packer, A. S. Desai, E. F. Lewis, M. Vaduganathan, M. P. Lefkowitz, J. L. Rouleau, V. C. Shi, M. R. Zile, Karl Swedberg, S. D. Solomon
Circulation - 2019
The Evolution of beta-Blockers in Coronary Artery Disease and Heart Failure (Part
1/5)

P. Joseph, Karl Swedberg, D. P. Leong, S. Yusuf
Journal of the American College of Cardiology - 2019
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection
Fraction

J. Tromp, L. Shen, P. S. Jhund, I. S. Anand, P. E. Carson, A. S. Desai, C. B. Granger, M. Komajda, R. S. McKelvie, M. A. Pfeffer, S. D. Solomon, L. Kober, Karl Swedberg, M. R. Zile, B. Pitt, C. S. P. Lam, J. J. V. McMurray
Journal of the American College of Cardiology - 2019
Outcomes and Effect of Treatment According to Etiology in HFrEF An Analysis of
PARADIGM-HF

C. Balmforth, J. Simpson, L. Shen, P. S. Jhund, M. Lefkowitz, A. R. Rizkala, J. L. Rouleau, V. Shi, S. D. Solomon, Karl Swedberg, M. R. Zile, M. Packer, J. J. V. McMurray
Jacc-Heart Failure - 2019
Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection
Fraction

L. Shen, P. S. Jhund, K. F. Docherty, M. C. Petrie, I. S. Anand, P. E. Carson, A. S. Desai, C. B. Granger, M. Komajda, R. S. McKelvie, M. A. Pfeffer, S. D. Solomon, Karl Swedberg, M. R. Zile, J. J. V. McMurray
Jacc-Heart Failure - 2019
Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF
Trial.

Pratyaksh K Srivastava, Brian L Claggett, Scott D Solomon, John J V McMurray, Milton Packer, Michael R Zile, Akshay S Desai, Jean L Rouleau, Karl Swedberg, Gregg C Fonarow
JAMA cardiology - 2018
Person-Centered Incontinence Care in Residential Care Facilities for Older Adults With Cognitive Decline: Feasibility and Preliminary Effects on Quality of Life and Quality of
Care

Helle Wijk, Kirsten Corazzini, Irma Lindström Kjellberg, Anton Kinnander, Eirini Alexiou, Karl Swedberg
J Gerontol Nurs - 2018
Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF
trial

N Bouabdallaoui, B Claggett, MR Zile, JJV McMurray, E O'Meara, M Packer, MF Prescott, Karl Swedberg, SD Solomon, JL Rouleau, PARADIGM-HF Investigators and Committees
European Journal of Heart Failure - 2018
Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network
meta-analysis

M. Komajda, M. Bohm, J. S. Borer, I. Ford, L. Tavazzi, M. Pannaux, Karl Swedberg
European Journal of Heart Failure - 2018
Sudden Death After Hospitalization for Heart Failure With Reduced Ejection Fraction (from the EVEREST
Trial)

M Vaduganathan, RB Patel, R J Mentz, H Subacius, NA Chatterjee, SJ Greene, AP Ambrosy, AP Maggioni, JE Udelson, Karl Swedberg, MA Konstam, CM O´Connor, J Butler, M Gheorghiade, F Zannad
Am J Cardiol - 2018
Natriuretic Peptides as Biomarkers of Treatment Response in Clinical Trials of Heart
Failure

M. Vaduganathan, B. Claggett, M. Packer, J. J. V. McMurray, J. L. Rouleau, M. R. Zile, Karl Swedberg, S. D. Solomon
Jacc-Heart Failure - 2018
Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart
Failure

K. Damman, M. Gori, B. Claggett, P. S. Jhund, M. Senni, M. P. Lefkowitz, M. F. Prescott, V. C. Shi, J. L. Rouleau, Karl Swedberg, M. R. Zile, M. Packer, A. S. Desai, S. D. Solomon, J. J. V. McMurray
Jacc-Heart Failure - 2018
Engaging patients in their medical
care

Karl Swedberg
Eur Heart J - 2018
Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF
study

P. Welsh, L. Kou, C. Yu, I. Anand, D. J. van Veldhuisen, A. P. Maggioni, A. S. Desai, S. D. Solomon, M. A. Pfeffer, S. Cheng, L. Gullestad, P. Aukrust, T. Ueland, Karl Swedberg, J. B. Young, M. W. Kattan, N. Sattar, J. J. V. McMurray
European journal of heart failure - 2018
Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction
spectrum

L. H. Lund, B. Claggett, J. K. Liu, C. S. Lam, P. S. Jhund, G. M. Rosano, Karl Swedberg, S. Yusuf, C. B. Granger, M. A. Pfeffer, J. J. V. McMurray, S. D. Solomon
European Journal of Heart Failure - 2018
Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial
(PARADIGM-HF)

U. M. Mogensen, J. J. Gong, P. S. Jhund, L. Shen, L. Kober, A. S. Desai, M. P. Lefkowitz, M. Packer, J. L. Rouleau, S. D. Solomon, B. L. Claggett, Karl Swedberg, M. R. Zile, G. Mueller-Velten, J. J. V. McMurray
European Journal of Heart Failure - 2018
Duration of chronic heart failure affects outcomes with preserved effects of heart rate reduction with ivabradine: findings from
SHIFT

M. Bohm, M. Komajda, J. S. Borer, I. Ford, C. Maack, L. Tavazzi, A. Moyne, Karl Swedberg
European journal of heart failure - 2018
Post hoc analyses of SHIFT and PARADIGM-HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: "Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial" by Bocchi et
al

FJA Ramirez, F Martinez, EA Gómez, C Demacq, CR Gimpelewicz, JL Rouleau, SD Solomon, Karl Swedberg, MR Zile, M Packer, JJV McMurray
Esc Heart Failure - 2018
Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure A Secondary Analysis of the PARADIGM-HF
Trial

A. Chandra, E. F. Lewis, B. L. Claggett, A. S. Desai, M. Packer, M. R. Zile, Karl Swedberg, J. L. Rouleau, V. C. Shi, M. P. Lefkowitz, T. Katova, J. J. V. McMurray, S. D. Solomon
Jama Cardiology - 2018
Person-centred telephone-support is effective in patients with chronic obstructive pulmonary disease and/or chronic heart failure – six-month follow-up of a randomised controlled
trial

Andreas Fors, Elin Blanck, Lilas Ali, Karl Swedberg, Inger Ekman
Heart Failure 2018 & World Congress of Acute Heart Failure - 2018
Effects of a person-centred telephone-support in patients with chronic obstructive pulmonary disease and/or chronic heart failure - A randomized controlled
trial

Andreas Fors, Elin Blanck, Lilas Ali, Ann Ekberg-Jansson, Michael Fu, Irma Lindström Kjellberg, Åsa Mäkitalo, Karl Swedberg, Charles Taft, Inger Ekman
Plos One - 2018
The year in cardiology 2017: Heart
failure

L. H. Lund, L. Køber, Karl Swedberg, F. Ruschitzka
European Heart Journal - 2018
Många med kronisk hjärtsvikt behandlas inte
optimalt.

Karl Swedberg, Michael Fu, Lars H Lund
Läkartidningen - 2018
Lessons for the monitoring of safety in clinical
trials

Karl Swedberg
European journal of heart failure - 2018
Incidence, Predictors, and Outcomes Associated With Hypotensive Episodes Among Heart Failure Patients Receiving Sacubitril/Valsartan or Enalapril The PARADIGM-HF Trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart
Failure)

O. Vardeny, B. Claggett, J. Kachadourian, S. M. Pearson, A. S. Desai, M. Packer, J. Rouleau, M. R. Zile, Karl Swedberg, M. Lefkowitz, V. Shi, J. J. V. McMurray, S. D. Solomon
Circulation-Heart Failure - 2018
Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart
failure.

Emil Wolsk, Brian Claggett, Lars Køber, Stuart Pocock, Salim Yusuf, Karl Swedberg, John J V McMurray, Christopher B Granger, Marc A Pfeffer, Scott D Solomon
European journal of heart failure - 2018
Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in
PARADIGM-HF

U. M. Mogensen, L. Kober, P. S. Jhund, A. S. Desai, M. Senni, S. L. Kristensen, A. Dukat, C. H. Chen, F. Ramires, M. P. Lefkowitz, M. F. Prescott, V. C. Shi, J. L. Rouleau, S. D. Solomon, Karl Swedberg, M. Packer, J. J. V. McMurray
European journal of heart failure - 2018
Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: Recurrent hospitalizations and
mortality

Elke Platz, Pardeep S. Jhund, Brian L. Claggett, Marc A. Pfeffer, Karl Swedberg, Christopher B. Granger, Salim Yusuf, Scott D. Solomon, John J. Mcmurray
European Journal of Heart Failure - 2018
Hyporesponsiveness to Darbepoetin Alfa in Patients With Heart Failure and Anemia in the RED-HF Study (Reduction of Events by Darbepoetin Alfa in Heart Failure) Clinical and Prognostic
Associations

P. van der Meer, N. G. Beverborg, M. A. Pfeffer, K. Olson, I. S. Anand, B. D. Westenbrink, J. J. V. McMurray, Karl Swedberg, J. B. Young, S. D. Solomon, D. J. van Veldhuisen
Circulation-Heart Failure - 2018
Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic
Cardiomyopathy

L. Shen, F. Ramires, F. Martinez, L. C. Bodanese, L. E. Echeverria, E. A. Gomez, W. T. Abraham, K. Dickstein, L. Kober, M. Packer, J. L. Rouleau, S. D. Solomon, Karl Swedberg, M. R. Zile, P. S. Jhund, C. R. Gimpelewicz, J. J. V. McMurray
Circulation. Heart failure - 2017
Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection
Fraction

U. M. Mogensen, P. S. Jhund, W. T. Abraham, A. S. Desai, K. Dickstein, M. Packer, J. L. Rouleau, S. D. Solomon, Karl Swedberg, M. R. Zile, L. Kober, J. J. V. McMurray
Journal of the American College of Cardiology - 2017
Declining Risk of Sudden Death in Heart
Failure

L. Shen, P. S. Jhund, M. C. Petrie, B. L. Claggett, S. Barlera, J. G. F. Cleland, H. J. Dargie, C. B. Granger, J. Kjekshus, L. Kober, R. Latini, A. P. Maggioni, M. Packer, B. Pitt, S. D. Solomon, Karl Swedberg, L. Tavazzi, John Wikstrand, F. Zannad, M. R. Zile, J. J. V. McMurray
New England Journal of Medicine - 2017
Achieving a Maximally Tolerated beta-Blocker Dose in Heart Failure Patients Is There Room for
Improvement?

A. S. Bhatt, A. D. DeVore, T. A. DeWald, Karl Swedberg, R. J. Mentz
Journal of the American College of Cardiology - 2017
Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF
Trial

A. S. Desai, O. Vardeny, B. Claggett, J. J. McMurray, M. Packer, Karl Swedberg, J. L. Rouleau, M. R. Zile, M. Lefkowitz, V. Shi, S. D. Solomon
JAMA cardiology - 2017
The effects of sacubitril/valsartan on coronary outcomes in
PARADIGM-HF

U. M. Mogensen, L. Kober, S. L. Kristensen, P. S. Jhund, J. J. Gong, M. P. Lefkowitz, A. R. Rizkala, J. L. Rouleau, V. C. Shi, Karl Swedberg, M. R. Zile, S. D. Solomon, M. Packer, J. J. V. McMurray
American Heart Journal - 2017
Independent academic Data Monitoring Committees for clinical trials in cardiovascular and cardiometabolic
diseases

G. S. Filippatos, P. de Graeff, J. J. Bax, J. J. Borg, J. G. Cleland, H. J. Dargie, M. Flather, I. Ford, T. Friede, B. Greenberg, C. Henon-Goburdhun, R. Holcomb, B. Horst, J. Lekakis, G. Mueller-Velten, A. G. Papavassiliou, K. Prasad, G. M. Rosano, T. Severin, W. Sherman, W. G. Stough, Karl Swedberg, L. Tavazzi, D. Tousoulis, P. Vardas, F. Ruschitzka, S. D. Anker
European Journal of Heart Failure - 2017
Comments on meta-analysis of ivabradine as adjuvant treatment for chronic heart failure by Mizzaci et
al

Karl Swedberg, M. Bohm, J. S. Borer, I. Ford, M. Komajda, L. Tavazzi
International Journal of Cardiology - 2017
Efficacy Profile of Ivabradine in Patients with Heart Failure plus Angina
Pectoris

J. S. Borer, Karl Swedberg, M. Komajda, I. Ford, L. Tavazzi, M. Bohm, C. Depre, Y. Wu, J. Maya, F. Dominjon
Cardiology - 2017
Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF
trial

T. Kitai, J. L. Grodin, R. J. Mentz, A. F. Hernandez, J. Butler, M. Metra, J. J. McMurray, P. W. Armstrong, R. C. Starling, C. M. O'Connor, Karl Swedberg, W. H. Tang
European Journal of Heart Failure - 2017
Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from
PARADIGM-HF

M. Bohm, R. Young, P. S. Jhund, S. D. Solomon, J. Gong, M. P. Lefkowitz, A. R. Rizkala, J. L. Rouleau, V. C. Shi, Karl Swedberg, M. R. Zile, M. Packer, J. J. McMurray
European Heart Journal - 2017
Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection
fraction

J. A. Cannon, L. Shen, P. S. Jhund, S. L. Kristensen, L. Kober, F. Chen, J. Gong, M. P. Lefkowitz, J. L. Rouleau, V. C. Shi, Karl Swedberg, M. R. Zile, S. D. Solomon, M. Packer, J. J. McMurray
European journal of heart failure - 2017
Person-centred care is effective after an event of acute coronary syndrome; particularly in patients with low educational level – two-year follow-up of a randomised controlled
trial.

Andreas Fors, Inger Ekman, Kerstin Ulin, Axel Wolf, Karl Swedberg
European Heart Journal, Volume 38, Issue suppl_1, 1 August 2017, ehx501.P625 - 2017
Can beta-blockers be used safely in non-cardiac surgery? Important lessons to be
learned

Karl Swedberg
European heart journal - 2017
Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial
Fibrillation

S. L. Kristensen, P. S. Jhund, U. M. Mogensen, R. Rorth, W. T. Abraham, A. Desai, K. Dickstein, J. L. Rouleau, M. R. Zile, Karl Swedberg, M. Packer, S. D. Solomon, L. Kober, J. J. V. McMurray
Circulation Heart Failure - 2017
Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical
Outcomes

Søren L. Kristensen, Pardeep S. Jhund, Matthew M.Y. Lee, Lars Køber, Scott D. Solomon, Christopher B. Granger, Salim Yusuf, Marc A. Pfeffer, Karl Swedberg, John J.V. McMurray
Cardiovascular Drugs and Therapy - 2017
Long-Term Effects of Flosequinan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure Primary Results of the PROFILE Trial After 24
Years

M. Packer, B. Pitt, J. L. Rouleau, Karl Swedberg, D. L. DeMets, L. Fisher
Jacc-Heart Failure - 2017
New medicinal products for chronic heart failure: advances in clinical trial design and efficacy
assessment

M. R. Cowie, G. S. Filippatos, Mdaa Garcia, S. D. Anker, A. Baczynska, D. M. Bloomfield, M. Borentain, K. B. Slot, M. Cronin, P. A. Doevendans, A. El-Gazayerly, C. Gimpelewicz, N. Honarpour, S. Janmohamed, H. Janssen, A. M. Kim, D. Lautsch, I. Laws, M. Lefkowitz, J. Lopez-Sendon, A. R. Lyon, F. I. Malik, J. J. V. McMurray, M. Metra, S. F. Perez, M. A. Pfeffer, S. J. Pocock, P. Ponikowski, K. Prasad, I. Richard-Lordereau, L. Roessig, G. M. C. Rosano, W. Sherman, W. G. Stough, Karl Swedberg, B. Tyl, F. Zannad, C. Boulton, P. De Graeff
European Journal of Heart Failure - 2017
Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF
trial

J. P. Seferovic, B. Claggett, S. B. Seidelmann, E. W. Seely, M. Packer, M. R. Zile, J. L. Rouleau, Karl Swedberg, M. Lefkowitz, V. C. Shi, A. S. Desai, J. J. McMurray, S. D. Solomon
Lancet Diabetes and Endocrinology - 2017
Heart rate and its reduction in chronic heart failure and
beyond

Aleksandra Nikolovska Vukadinović, Davor Vukadinović, Jeffrey Borer, Martin Cowie, Michel Komajda, Mitja Lainscak, Karl Swedberg, Michael Böhm
European Journal of Heart Failure - 2017
Impact of eplerenone on cardiovascular outcomes in heart failure patients with
hypokalaemia

Patrick Rossignol, Nicolas Girerd, George Bakris, Orly Vardeny, Brian Claggett, John J.V. McMurray, Karl Swedberg, Henry Krum, Dirk J. van Veldhuisen, Harry Shi, Sean Spanyers, John Vincent, Renaud Fay, Zohra Lamiral, Scott D. Solomon, Faiez Zannad, Bertram Pitt
European Journal of Heart Failure - 2017
Effects of person-centred care after an event of acute coronary syndrome: Two-year follow-up of a randomised controlled
trial

Andreas Fors, Karl Swedberg, Kerstin Ulin, Axel Wolf, Inger Ekman
International Journal of Cardiology - 2017
Health-Related Quality of Life Outcomes in
PARADIGM-HF

Eldrin F. Lewis, Brian L. Claggett, John J.V. McMurray, Milton Packer, Martin P. Lefkowitz, Jean L. Rouleau, Jiankang Liu, Victor C. Shi, Michael R. Zile, Akshay S. Desai, Scott D. Solomon, Karl Swedberg
Circulation: Heart Failure - 2017
Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity: Insight from the EMPHASIS-HF
trial

A. Olivier, B. Pitt, N. Girerd, Z. Lamiral, J. L. Machu, J. J. McMurray, Karl Swedberg, D. J. van Veldhuisen, T. J. Collier, S. J. Pocock, P. Rossignol, F. Zannad, A. Pizard
European Journal of Heart Failure - 2017
A person-centred intervention at distance for patients with chronic obstructive pulmonary disease and/or chronic heart
failure

Lilas Ali, Andreas Fors, Karl Swedberg, Inger Ekman
International Forum on Quality and Safety in Healthcare, London. - 2017
Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure Primary Results of the ENABLE
Trials

M. Packer, J. J. V. McMurray, H. Krum, W. Kiowski, B. M. Massie, A. Caspi, C. M. Pratt, M. C. Petrie, D. DeMets, I. Kobrin, S. Roux, Karl Swedberg
Jacc-Heart Failure - 2017
Editorial commentary: Guidelines for the treatment of chronic heart
failure

Karl Swedberg
Trends in Cardiovascular Medicine - 2017
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable
Cardioverter-Defibrillators

K. C. Bilchick, Y. F. Wang, A. Cheng, J. P. Curtis, K. Dharmarajan, G. J. Stukenborg, R. Shadman, I. Anand, L. H. Lund, U. Dahlstrom, U. Sartipy, A. Maggioni, Karl Swedberg, C. O'Conner, W. C. Levy
Journal of the American College of Cardiology - 2017
Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve
trials

A. H. Abdul-Rahim, A. C. Perez, R. L. MacIsaac, P. S. Jhund, B. L. Claggett, P. E. Carson, M. Komajda, R. S. McKelvie, M. R. Zile, Karl Swedberg, S. Yusuf, M. A. Pfeffer, S. D. Solomon, G. Y. H. Lip, K. R. Lees, J. J. V. McMurray, Preserved Candesartan Heart Failure Assessme; Irbesartan Heart Failure
European Heart Journal - 2017
Impact of Body Mass Index on the Accuracy of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide for Predicting Outcomes in Patients With Chronic Heart Failure and Reduced Ejection Fraction: Insights From the PARADIGM-HF Study (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure
Trial)

Jr. Nadruz, B. L. Claggett, J. J. McMurray, M. Packer, M. R. Zile, J. L. Rouleau, A. S. Desai, Karl Swedberg, M. Lefkowitz, V. C. Shi, M. F. Prescott, S. D. Solomon
Circulation - 2016
Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart
Failure

M. R. Zile, B. L. Claggett, M. F. Prescott, J. J. McMurray, M. Packer, J. L. Rouleau, Karl Swedberg, A. S. Desai, J. Gong, V. C. Shi, S. D. Solomon
Journal of the American College of Cardiology - 2016
Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study
programme

K. Damman, S. D. Solomon, M. A. Pfeffer, Karl Swedberg, S. Yusuf, J. B. Young, J. L. Rouleau, C. B. Granger, J. J. McMurray
European journal of heart failure - 2016
Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation: The PARADIGM-HF
Trial

S. D. Solomon, B. Claggett, M. Packer, A. Desai, M. R. Zile, Karl Swedberg, J. Rouleau, V. Shi, M. Lefkowitz, J. J. McMurray
JACC. Heart failure - 2016
Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF
trial

O. Vardeny, B. Claggett, M. Packer, M. R. Zile, J. Rouleau, Karl Swedberg, J. R. Teerlink, A. S. Desai, M. Lefkowitz, V. Shi, J. J. McMurray, S. D. Solomon
European journal of heart failure - 2016
Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose
adjustment

N. M. Hawkins, P. S. Jhund, A. Pozzi, E. O'Meara, S. D. Solomon, C. B. Granger, S. Yusuf, M. A. Pfeffer, Karl Swedberg, M. C. Petrie, S. Virani, J. J. V. McMurray
European Journal of Heart Failure - 2016
Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data
meta-analysis.

C Berry, K K Poppe, G D Gamble, N J Earle, J A Ezekowitz, I B Squire, J J V McMurray, F A McAlister, M Komajda, Karl Swedberg, A P Maggioni, A Ahmed, G A Whalley, R N Doughty, L Tarantini
QJM : monthly journal of the Association of Physicians - 2016
Effectiveness of person-centred care after acute coronary syndrome in relation to educational level: Subgroup analysis of a two-armed randomised controlled
trial

Andreas Fors, Hanna Gyllensten, Karl Swedberg, Inger Ekman
International journal of cardiology - 2016
Treatment of diabetes and heart failure: joint
forces

Karl Swedberg, L. Ryden
European Heart Journal - 2016
Person-centred care for patients with chronic heart failure - a cost-utility
analysis

Elisabeth K Hansson, Inger Ekman, Karl Swedberg, Axel Wolf, Kerstin Dudas, Lars Ehlers, Lars-Eric Olsson
European Journal of Cardiovascular Nursing - 2016
Challenges to Data Monitoring Committees When Regulatory Authorities
Intervene

Karl Swedberg, J. S. Borer, B. Pitt, S. Pocock, J. Rouleau
New England Journal of Medicine - 2016
Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF)
Trial

S. D. Solomon, B. Claggett, A. S. Desai, M. Packer, M. Zile, Karl Swedberg, J. L. Rouleau, V. C. Shi, R. C. Starling, O. Kozan, A. Dukat, M. P. Lefkowitz, J. J. McMurray
Circ Heart Fail - 2016
Influenza Vaccination in Patients With Chronic Heart Failure The PARADIGM-HF
Trial

O. Vardeny, B. Claggett, J. A. Udell, M. Packer, M. Zile, J. Rouleau, Karl Swedberg, A. S. Desai, M. Lefkowitz, V. Shi, J. J. V. McMurray, S. D. Solomon
Jacc-Heart Failure - 2016
Temporal Changes in Postdischarge Mortality Risk After Hospitalization for Heart Failure (from the EVEREST
Trial)

T. D. Cook, S. J. Greene, A. P. Kalogeropoulos, G. C. Fonarow, R. Zea, Karl Swedberg, F. Zannad, A. P. Maggioni, M. A. Konstam, M. Gheorghiade, J. Butler
American Journal of Cardiology - 2016
Geographic variations in the PARADIGM-HF heart failure
trial

S. L. Kristensen, F. Martinez, P. S. Jhund, J. L. Arango, J. Belohlavek, S. Boytsov, W. Cabrera, E. Gomez, A. A. Hagege, J. Huang, S. Kiatchoosakun, K. S. Kim, I. Mendoza, M. Senni, I. B. Squire, D. Vinereanu, R. C. Wong, J. Gong, M. P. Lefkowitz, A. R. Rizkala, J. L. Rouleau, V. C. Shi, S. D. Solomon, Karl Swedberg, M. R. Zile, M. Packer, J. J. McMurray
European heart journal - 2016
From CONSENSUS to SAVE: the Early Development of Inhibition of the Renin-Angiotensin System in the Treatment of Chronic Heart
Failure

Karl Swedberg
Journal of cardiac failure - 2016
Effect of Visit-to-Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial (SHIFT)
Trial

M. Bohm, M. Robertson, J. Borer, I. Ford, M. Komajda, F. Mahfoud, S. Ewen, Karl Swedberg, L. Tavazzi
Journal of the American Heart Association - 2016
Chronic exposure to ivabradine reduces readmissions in the vulnerable phase after hospitalization for worsening systolic heart failure: a post-hoc analysis of
SHIFT

M. Komajda, L. Tavazzi, Karl Swedberg, M. Bohm, J. S. Borer, A. Moyne, I. Ford
European journal of heart failure - 2016
Aspirin does not reduce the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in patients with systolic heart failure and mild symptoms: an analysis of the EMPHASIS-HF
study

K. L. Chin, T. J. Collier, B. Pitt, J. J. McMurray, Karl Swedberg, D. J. van Veldhuisen, S. J. Pocock, J. Vincent, E. Turgonyi, F. Zannad, H. Krum
European journal of heart failure - 2016
Sakubitril–valsartan är en ny hörnsten i
hjärtsviktsterapin

L. H. Lund, Michael Fu, Karl Swedberg
Lakartidningen - 2016
Health-care improvements in a financially constrained
environment

Inger Ekman, R. Busse, E. van Ginneken, C. Van Hoof, L. van Ittersum, A. Klink, J. A. Kremer, M. Miraldo, A. Olauson, W. De Raedt, M. Rosen-Zvi, V. Strammiello, Jan Törnell, Karl Swedberg
Lancet - 2016
Effects of sacubitril/valsartan in the PARADIGM-HF trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) according to background
therapy

N. Okumura, P. S. Jhund, J. Gong, M. P. Lefkowitz, A. R. Rizkala, J. L. Rouleau, V. C. Shi, Karl Swedberg, M. R. Zile, S. D. Solomon, M. Packer, J. J. V. McMurray
Circulation Heart Failure - 2016
An eHealth Diary and Symptom-Tracking Tool Combined With Person-Centered Care for Improving Self-Efficacy After a Diagnosis of Acute Coronary Syndrome: A Substudy of a Randomized Controlled
Trial.

Axel Wolf, Andreas Fors, Kerstin Ulin, Jörgen Thorn, Karl Swedberg, Inger Ekman
Journal of Medical Internet Research - 2016
Effects of an eHealth intervention combined with person-centered care throughout the continuum of care for patients diagnosed with acute coronary
syndrome

Axel Wolf, Andreas Fors, Kerstin Ulin, Jörgen Thorn, Karl Swedberg, Inger Ekman
European Journal of Cardiovascular Nursing - 2016
Factors Associated With Noncompletion During the Run-In Period Before Randomization and Influence on the Estimated Benefit of LCZ696 in the PARADIGM-HF
Trial

A. S. Desai, S. Solomon, B. Claggett, J. J. V. McMurray, J. Rouleau, Karl Swedberg, M. Zile, M. Lefkowitz, V. Shi, M. Packer
Circulation-Heart Failure - 2016
Optimizing the Management of Heart Failure with Preserved Ejection Fraction in the Elderly by Targeting Comorbidities
(OPTIMIZE-HFPEF).

Michael Fu, Jingmin Zhou, Erik Thunström, Torbjörn Almgren, Ludger Grote, Entela Bollano, Maria Schaufelberger, Magnus C Johansson, Max Petzold, Karl Swedberg, Bert Andersson
Journal of cardiac failure - 2016
Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure
Trial

S. L. Kristensen, D. Preiss, P. S. Jhund, I. Squire, J. S. Cardoso, B. Merkely, F. Martinez, R. C. Starling, A. S. Desai, M. P. Lefkowitz, A. R. Rizkala, J. L. Rouleau, V. C. Shi, S. D. Solomon, Karl Swedberg, M. R. Zile, J. J. V. McMurray, M. Packer
Circulation-Heart Failure - 2016
Person-centred care after acute coronary syndrome is effective in persons with lower socioeconomic
position

Andreas Fors, Hanna Gyllensten, Karl Swedberg, Inger Ekman
International Forum on Quality and Safety in Healthcare, 12-15 April 2016, Gothenburg, Sweden - 2016
Influence of Sacubitril/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure
Hospitalization

A. S. Desai, B. L. Claggett, M. Packer, M. R. Zile, J. L. Rouleau, Karl Swedberg, V. Shi, M. Lefkowitz, R. Starling, J. Teerlink, J. J. V. McMurray, S. D. Solomon
Journal of the American College of Cardiology - 2016
Non-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from
SHIFT

M. Bohm, S. M. Lloyd, I. Ford, J. S. Borer, S. Ewen, U. Laufs, F. Mahfoud, J. Lopez-Sendon, P. Ponikowski, L. Tavazzi, Karl Swedberg, M. Komajda
European Journal of Heart Failure - 2016
Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST
Trial

A. P. Ambrosy, H. Khan, J. E. Udelson, R. J. Mentz, O. Chioncel, S. J. Greene, M. Vaduganathan, H. P. Subacuis, M. A. Konstam, Karl Swedberg, F. Zannad, A. P. Maggioni, M. Gheorghiade, J. Butler
Circulation-Heart Failure - 2016
Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF
Trial)

M. Metra, R. J. Mentz, A. F. Hernandez, G. M. Heizer, P. W. Armstrong, N. Clausell, R. Corbalan, M. R. Costanzo, K. Dickstein, M. E. Dunlap, J. A. Ezekowitz, J. G. Howlett, M. Komajda, H. Krum, C. Lombardi, G. C. Fonarow, J. J. V. McMurray, M. S. Nieminen, Karl Swedberg, A. A. Voors, R. C. Starling, J. R. Teerlink, C. M. O'Connor
American Journal of Cardiology - 2016
Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting: Evidence From the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial
(PARADIGM-HF)

N. Okumura, P. S. Jhund, J. J. Gong, M. P. Lefkowitz, A. R. Rizkala, J. L. Rouleau, V. C. Shi, Karl Swedberg, M. R. Zile, S. D. Solomon, M. Packer, J. J. V. McMurray
Circulation - 2016
Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM
program

A. Vazir, B. Claggett, P. Jhund, D. Castagno, H. Skali, S. Yusuf, Karl Swedberg, C. B. Granger, J. J. McMurray, M. A. Pfeffer, S. D. Solomon
European Heart Journal - 2015
Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT
trial

M. Komajda, L. Tavazzi, B. G. Francq, M. Bohm, J. S. Borer, I. Ford, Karl Swedberg
European journal of heart failure - 2015
Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT
Trial)

M. Bohm, M. Robertson, I. Ford, J. S. Borer, M. Komajda, I. Kindermann, C. Maack, M. Lainscak, Karl Swedberg, L. Tavazzi
The American journal of cardiology - 2015
Person-centred care improves self-efficacy after acute coronary
syndrome

Andreas Fors, Kerstin Ulin, Jörgen Thorn, Inger Ekman, Karl Swedberg
International Forum on Quality and Safety in Healthcare, 21-24 April 2015, London, UK - 2015
Pharmacologic Options for the Management of Systolic Heart Failure: Examining Underlying
Mechanisms

G. B. J. Mancini, J. G. Howlett, J. Borer, P. P. Liu, M. R. Mehra, M. Pfeffer, Karl Swedberg, J. C. Tardif
Canadian Journal of Cardiology - 2015
2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery
(EACTS).

Yehuda Adler, Philippe Charron, Massimo Imazio, Luigi Badano, Gonzalo Barón-Esquivias, Jan Bogaert, Antonio Brucato, Pascal Gueret, Karin Klingel, Christos Lionis, Bernhard Maisch, Bongani Mayosi, Alain Pavie, Arsen D Ristić, Manel Sabaté Tenas, Petar Seferovic, Karl Swedberg, Witold Tomkowski
European heart journal - 2015
Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney
disease.

Natalie A Bello, Eldrin F Lewis, Akshay S Desai, Inder S Anand, Henry Krum, John J V McMurray, Kurt Olson, Scott D Solomon, Karl Swedberg, Dirk J van Veldhuisen, James B Young, Marc A Pfeffer
European journal of heart failure - 2015
Estimating the Long-Term Treatment Benefits of
Sacubitril-Valsartan

B. Claggett, M. Packer, J.J.V. McMurray, Karl Swedberg, J. Rouleau, M.R. Zile, P. Jhund, M. Lefkowitz, V. Shi, S.D. Solomon
New England Journal of Medicine - 2015
Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from
PARADIGM-HF

P. S. Jhund, M. Fu, E. Bayram, C. H. Chen, M. Negrusz-Kawecka, A. Rosenthal, A. S. Desai, M. P. Lefkowitz, A. R. Rizkala, J. L. Rouleau, V. C. Shi, S. D. Solomon, Karl Swedberg, M. R. Zile, J. J. V. McMurray, M. Packer
European Heart Journal - 2015
Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the EVEREST
trial

H. Khan, S. J. Greene, G. C. Fonarow, A. P. Kalogeropoulos, A. P. Ambrosy, A. P. Maggioni, F. Zannad, M. A. Konstam, Karl Swedberg, C. W. Yancy, M. Gheorghiade, J. Butler
European Journal of Heart Failure - 2015
Effect of Combining Ivabradine and beta-Blockers: Focus on the Use of Carvedilol in the SHIFT
Population

E. A. Bocchi, M. Bohm, J. S. Borer, I. Ford, M. Komajda, Karl Swedberg, L. Tavazzi
Cardiology - 2015
Comparing LCZ696 With Enalapril According to Baseline Risk Using the MAGGIC and EMPHASIS-HF Risk
Scores

J. Simpson, P. S. Jhund, J. S. Cardoso, F. Martinez, A. Mosterd, F. Ramires, A. R. Rizkala, M. Senni, I. Squire, J. J. Gong, M. P. Lefkowitz, V. C. Shi, A. S. Desai, J. L. Rouleau, Karl Swedberg, M. R. Zile, J. J. V. McMurray, M. Packer, S. D. Solomon
Journal of the American College of Cardiology - 2015
A novel method to predict the proportional risk of sudden cardiac death in heart failure: Derivation of the Seattle Proportional Risk
Model

R. Shadman, J. E. Poole, T. F. Dardas, D. Mozaffarian, J. G. F. Cleland, Karl Swedberg, A. P. Maggioni, I. S. Anand, P. E. Carson, A. B. Miller, W. C. Levy
Heart Rhythm - 2015
Repeated Heart Rate Measurement and Cardiovascular Outcomes in Left Ventricular Systolic
Dysfunction

V. Hamill, I. Ford, K. Fox, M. Bohm, J. S. Borer, R. Ferrari, M. Komajda, P. G. Steg, L. Tavazzi, M. Tendera, Karl Swedberg
American Journal of Medicine - 2015
Commentary: Swedish initiative on person centred
care

Inger Ekman, H. Hedman, Karl Swedberg, Catarina Wallengren Gustafsson
BMJ - 2015
Effect of ivabradine on early readmissions after hospitalization for worsening heart
failure

J. S. Borer, M. Bohm, I. Ford, M. Komajda, Karl Swedberg, L. Tavazzi
JACC Heart Failure - 2015
Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF
trial

N. Girerd, T. Collier, S. Pocock, H. Krum, J. J. McMurray, Karl Swedberg, D. J. van Veldhuisen, J. Vincent, B. Pitt, F. Zannad
European Heart Journal - 2015
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure
patients

A. S. Desai, J. J. V. McMurray, M. Packer, Karl Swedberg, J. L. Rouleau, F. B. Chen, J. J. Gong, A. R. Rizkala, A. Brahimi, B. Claggett, P. V. Finn, L. H. Hartley, J. K. Liu, M. Lefkowitz, V. Shi, M. R. Zile, S. D. Solomon
European Heart Journal - 2015
Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart
Failure

M. Packer, J. J. McMurray, A. S. Desai, J. Gong, M. P. Lefkowitz, A. R. Rizkala, J. L. Rouleau, V. Shi, S. D. Solomon, Karl Swedberg, M. R. Zile, K. Andersen, J. L. Arango, M. Arnold, J. Belohlavek, M. Bohm, S. A. Boytsov, L. J. Burgess, W. Cabrera, C. Calvo, C. H. Chen, A. Dukat, Y. C. Duarte, A. Erglis, Michael Fu, E. A. Gomez, A. Gonzalez-Medina, A. A. Hagege, J. Huang, T. M. Katova, S. Kiatchoosakun, K. S. Kim, O. Kozan, E. A. Llamas, F. Martinez, B. Merkely, I. Mendoza, A. Mosterd, M. Negrusz-Kawecka, K. Peuhkurinen, F. Ramires, J. Refsgaard, A. Rosenthal, M. Senni, A. S. Sibulo, J. S. Cardoso, I. B. Squire, R. C. Starling, J. R. Teerlink, J. Vanhaecke, D. Vinereanu, R. C. Wong
Circulation - 2015
Clinical outcomes according to QRS duration and morphology in the Eplerenone in Mild Patients: Hospitalization and SurvIval Study in Heart Failure
(EMPHASIS-HF)

J. A. Cannon, T. J. Collier, L. Shen, Karl Swedberg, H. Krum, D. J. van Veldhuisen, J. Vincent, S. J. Pocock, B. Pitt, F. Zannad, J. J. V. McMurray
European Journal of Heart Failure - 2015
Top ten risk factors for morbidity and mortality in patients with chronic systolic heart failure and elevated heart rate: The SHIFT Risk
Model

I. Ford, M. Robertson, M. Komajda, M. Bohm, J. S. Borer, L. Tavazzi, Karl Swedberg
International Journal of Cardiology - 2015
Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient
meta-analysis.

Colette E Jackson, Davide Castagno, Aldo P Maggioni, Lars Køber, Iain B Squire, Karl Swedberg, Bert Andersson, A Mark Richards, Antoni Bayes-Genis, Christophe Tribouilloy, Joanna Dobson, Cono A Ariti, Katrina K Poppe, Nikki Earle, Gillian Whalley, Stuart J Pocock, Robert N Doughty, John J V McMurray
European heart journal - 2015
Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter
substudy

M. Bohm, J. S. Borer, J. Camm, I. Ford, S. M. Lloyd, M. Komajda, L. Tavazzi, M. Talajic, M. Lainscak, J. C. Reil, C. Ukena, Karl Swedberg
European Journal of Heart Failure - 2015
Person-centred care after acute coronary syndrome, from hospital to primary care - A randomised controlled
trial

Andreas Fors, Inger Ekman, Charles Taft, Cecilia Björkelund, K. Frid, Maria E H Larsson, Jörgen Thorn, Kerstin Ulin, Axel Wolf, Karl Swedberg
International Journal of Cardiology - 2015
Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity)
Programme

A. A. Badar, A. C. Perez-Moreno, N. M. Hawkins, A. P. T. Brunton, P. S. Jhund, C. M. Wong, S. D. Solomon, C. B. Granger, S. Yusuf, M. A. Pfeffer, Karl Swedberg, R. S. Gardner, M. C. Petrie, J. J. V. McMurray
European Journal of Heart Failure - 2015
A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart
failure

J. McMurray, M. Packer, A. Desai, J. Gong, N. Greenlaw, M. Lefkowitz, A. Rizkala, V. Shi, J. Rouleau, S. Solomon, Karl Swedberg, M. R. Zile, K. Andersen, J. L. Arango, M. Arnold, J. Belohlavek, M. Bohm, S. Boytsov, L. Burgess, W. Cabrera, C. H. Chen, A. Erglis, Michael Fu, E. Gomez, A. Gonzalez, A. A. Hagege, T. Katova, S. Kiatchoosakun, K. S. Kim, E. Bayram, F. Martinez, B. Merkely, I. Mendoza, A. Mosterd, M. Negrusz-Kawecka, K. Peuhkurinen, F. Ramires, J. Refsgaard, M. Senni, A. S., Jr. Sibulo, J. Silva-Cardoso, I. Squire, R. C. Starling, D. Vinereanu, J. R. Teerlink, R. Wong
European Heart Journal - 2015
Changes in Serum Potassium Levels During Hospitalization in Patients With Worsening Heart Failure and Reduced Ejection Fraction (from the EVEREST
Trial)

S. S. Khan, U. Campia, O. Chioncel, F. Zannad, P. Rossignol, A. P. Maggioni, Karl Swedberg, M. A. Konstam, M. Senni, S. Nodari, M. Vaduganathan, H. Subacius, J. Butler, M. Gheorghiade
American Journal of Cardiology - 2015
International Geographic Variation in Event Rates in Trials of Heart Failure With Preserved and Reduced Ejection
Fraction

S. L. Kristensen, L. Kober, P. S. Jhund, S. D. Solomon, J. K. Kjekshus, R. S. McKelvie, M. R. Zile, C. B. Granger, John Wikstrand, M. Komajda, P. E. Carson, M. A. Pfeffer, Karl Swedberg, Hans Wedel, S. Yusuf, J. J. McMurray
Circulation - 2015
Heart failure therapies in 2014: Mixed results for heart failure
therapies

Karl Swedberg
Nature Reviews Cardiology - 2015
Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering
properties

D. Dobre, J. S. Borer, K. Fox, Karl Swedberg, K. F. Adams, J. G. Cleland, A. Cohen-Solal, M. Gheorghiade, F. Gueyffier, C. M. O'Connor, M. Fiuzat, A. Patak, I. L. Pina, G. Rosano, H. N. Sabbah, L. Tavazzi, F. Zannad
European Journal of Heart Failure - 2014
Tillämpning av personcentrering inom hälso- och
sjukvård

Inger Ekman, A Norberg, Karl Swedberg
Personcentrering inom hälso- och sjukvård: från filosofi till praktik. Red. Inger Ekman. - 2014
The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient
data

R. Padwal, F. A. McAlister, J. J. McMurray, M. R. Cowie, M. Rich, S. Pocock, Karl Swedberg, A. Maggioni, G. Gamble, C. Ariti, N. Earle, G. Whalley, K. K. Poppe, R. N. Doughty, A. Bayes-Genis
International Journal of Obesity - 2014
WE CARE: COORDINATING THE DEVELOPMENT OF AN
R&D

Inger Ekman, Karl Swedberg, Reinhard Busse, Ewout van Ginneken
Eurohealth - 2014
Influence of Prior Heart Failure Hospitalization on Cardiovascular Events in Patients with Reduced and Preserved Ejection
Fraction

N. A. Bello, B. Claggett, A. S. Desai, J. J. McMurray, C. B. Granger, S. Yusuf, Karl Swedberg, M. A. Pfeffer, S. D. Solomon
Circulation Heart Failure - 2014
The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical
trials

S. D. Anker, S. Agewall, M. Borggrefe, M. Calvert, J. Jaime Caro, M. R. Cowie, I. Ford, J. A. Paty, J. P. Riley, Karl Swedberg, L. Tavazzi, I. Wiklund, P. Kirchhof
European Heart Journal - 2014
Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure (from the SHIFT
study)

J. S. Borer, M. Böhm, I. Ford, M. Robertson, M. Komajda, L. Tavazzi, Karl Swedberg
American Journal of Cardiology - 2014
Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients with Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo Additional to Optimal Medical Therapy: Results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure
(EMPHASIS-HF)

P. Rossignol, D. Dobre, J. J. McMurray, Karl Swedberg, H. Krum, D. J. van Veldhuisen, H. Shi, M. Messig, J. Vincent, N. Girerd, G. Bakris, B. Pitt, F. Zannad
Circulation Heart Failure - 2014
Heart failure in young adults: 20-year trends in hospitalization, aetiology, and case fatality in
Sweden

Anders Barasa, Maria Schaufelberger, Georg Lappas, Karl Swedberg, Mikael Dellborg, Annika Rosengren
European Heart Journal - 2014
Relation of Serum Uric Acid Levels and Outcomes Among Patients Hospitalized for Worsening Heart Failure With Reduced Ejection Fraction (from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan
Trial)

M. Vaduganathan, S. J. Greene, A. P. Ambrosy, R. J. Mentz, H. P. Subacius, O. Chioncel, A. P. Maggioni, Karl Swedberg, F. Zannad, M. A. Konstam, M. Senni, M. M. Givertz, J. Butler, M. Gheorghiade
American Journal of Cardiology - 2014
Influence of hospitalization for cardiovascular versus noncardiovascular reasons on subsequent mortality in patients with chronic heart failure across the spectrum of ejection
fraction

A. S. Desai, B. Claggett, M. A. Pfeffer, N. Bello, P. V. Finn, C. B. Granger, J. J. McMurray, S. Pocock, Karl Swedberg, S. Yusuf, S. D. Solomon
Circulation Heart Failure - 2014
Disease-specific health status as a predictor of
mortality

Inger Ekman, Karl Swedberg, M. Bohm
European Journal of Heart Failure - 2014
Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in
SHIFT

M. Komajda, M. Bohm, J. S. Borer, I. Ford, M. Robertson, A. J. Manolis, L. Tavazzi, Karl Swedberg
European Journal of Heart Failure - 2014
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart
Failure

J. J. V. McMurray, M. Packer, A. S. Desai, J. J. Gong, M. P. Lefkowitz, A. R. Rizkala, J. L. Rouleau, V. C. Shi, S. D. Solomon, Karl Swedberg, M. R. Zile
New England Journal of Medicine - 2014
Risk stratification for sudden cardiac death: current status and challenges for the
future

H. J. Wellens, P. J. Schwartz, F. W. Lindemans, A. E. Buxton, J. J. Goldberger, S. H. Hohnloser, H. V. Huikuri, S. Kaab, M. T. La Rovere, M. Malik, R. J. Myerburg, M. L. Simoons, Karl Swedberg, J. Tijssen, A. A. Voors, A. A. Wilde
European Heart Journal - 2014
Influence of Previous Heart Failure Hospitalization on Cardiovascular Events in Patients With Reduced and Preserved Ejection
Fraction

N. A. Bello, B. Claggett, A. S. Desai, J. J. V. McMurray, C. B. Granger, S. Yusuf, Karl Swedberg, M. A. Pfeffer, S. D. Solomon
Circulation-Heart Failure - 2014
Baseline characteristics and treatment of patients in Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial
(PARADIGM-HF)

J. J. McMurray, M. Packer, A. S. Desai, J. Gong, M. Lefkowitz, A. R. Rizkala, J. L. Rouleau, V. C. Shi, S. Solomon, Karl Swedberg, M. R. Zile
European Journal of Heart Failure - 2014
Clinical Profile and Prognostic Value of Anemia at the Time of Admission and Discharge Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction: Findings From the EVEREST
Trial

R. J. Mentz, S. J. Greene, A. P. Ambrosy, M. Vaduganathan, H. P. Subacius, Karl Swedberg, A. P. Maggioni, S. Nodari, P. Ponikowski, S. D. Anker, J. Butler, M. Gheorghiade
Circulation Heart Failure - 2014
Relaxing from
dyspnoea

Karl Swedberg
European Heart Journal - 2014
The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from
SHIFT

A. A. Voors, D. J. van Veldhuisen, M. Robertson, I. Ford, J. S. Borer, M. Bohm, M. Komajda, Karl Swedberg, L. Tavazzi, Shift investigators on behalf of the
European Journal of Heart Failure - 2014
The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND-HF
Trial

M. Toma, J. A. Ezekowitz, J. A. Bakal, C. M. O'Connor, A. F. Hernandez, M. R. Sardar, R. Zolty, B. M. Massie, Karl Swedberg, P. W. Armstrong, R. C. Starling
European Journal of Heart Failure - 2014
Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to
CHARM-Preserved

J. K. Rogers, S. J. Pocock, J. J. V. McMurray, C. B. Granger, E. L. Michelson, J. Ostergren, M. A. Pfeffer, S. D. Solomon, Karl Swedberg, S. Yusuf
European Journal of Heart Failure - 2014
Predicting survival in heart failure: a risk score based on 39 372 patients from 30
studies.

Stuart J Pocock, Cono A Ariti, John J V McMurray, Aldo Maggioni, Lars Køber, Iain B Squire, Karl Swedberg, Joanna Dobson, Katrina K Poppe, Gillian A Whalley, Rob N Doughty
European heart journal - 2013
Efficacy of person-centred care as an intervention in controlled trials – a systematic
review

Lars-Eric Olsson, Eva Jakobsson, Karl Swedberg, Inger Ekman
Journal of Clinical Nursing - 2013
The person-centred approach to an ageing
society

Inger Ekman, Nicky Britten, Jens Bördin, Christiano Codagnone, Staffan Edén, Daniel Forslund, Pam Fredman, Lars Grip, Håkan Hedman, Ted Hesselbom, Iris van Dijk Härd, Olle Larkö, Irma Lindström, Lisa Lindström, Astrid Norberg, Anders Olauson, Henrik Rosén, Akbar Seddig, Alan Lennant, Christoph Westerteichert, Björn Ålsnäs, Karl Swedberg
European Journal for Person Centered Healthcare - 2013
Darbepoetin alfa in systolic heart failure -
Correspondence

Karl Swedberg, J. J. McMurray, J. B. Young
New England Journal of Medicine - 2013
The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF
trial

T. J. Collier, S. J. Pocock, J. J. McMurray, F. Zannad, H. Krum, D. J. van Veldhuisen, Karl Swedberg, H. Shi, J. Vincent, B. Pitt
European Heart Journal - 2013
Uncertainty in illness among patients with chronic heart failure is less in person-centred care than in usual
care

Kerstin Dudas, Lars-Eric Olsson, Axel Wolf, Karl Swedberg, Charles Taft, Maria Schaufelberger, Inger Ekman
European Journal of Cardiovascular Nursing - 2013
Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with
tolvaptan

P. J. Hauptman, J. Burnett, M. Gheorghiade, L. Grinfeld, M. A. Konstam, D. Kostic, H. B. Krasa, A. Maggioni, J. Ouyang, Karl Swedberg, F. Zannad, C. Zimmer, J. E. Udelson
Journal of Cardiac Failure - 2013
Influence of background treatment with mineralocorticoid receptor antagonists on ivabradine's effects in patients with chronic heart
failure

M. Komajda, M. Bohm, J. Borer, I. Ford, H. Krum, A. Tase, L. Tavazzi, Karl Swedberg
European journal of heart failure - 2013
Trends in stroke incidence after hospitalization for atrial fibrillation in Sweden 1987 to
2006

Lars G. Olsson, Karl Swedberg, Georg Lappas, S. Stewart, Annika Rosengren
International journal of cardiology - 2013
Salt and fluid restriction is effective in patients with chronic heart
failure

Henriette Philipson, Inger Ekman, Helene Berteus Forslund, Karl Swedberg, Maria Schaufelberger
European Journal of Heart Failure - 2013
Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST
trial

S. Sarma, R. J. Mentz, M. J. Kwasny, A. J. Fought, M. Huffman, H. Subacius, S. Nodari, M. Konstam, Karl Swedberg, A. P. Maggioni, F. Zannad, R. O. Bonow, M. Gheorghiade
European journal of heart failure - 2013
Inhibition of the Renin-Angiotensin System Reduces the Rise in Serum Aldosterone in Acute Coronary Syndrome Patients with Preserved Left Ventricular Function: Observations from the AVANT GARDE-TIMI 43
Trial

J. A. Udell, D. A. Morrow, E. Braunwald, Karl Swedberg, C. Bode, N. Rifai, P. C. Brunel, M. F. Prescott, F. Ren, E. B. Hoffman, B. M. Scirica
Clinical Chemistry - 2013
Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT
study

Michael Böhm, Jeffrey Borer, Ian Ford, Jose R. Gonzalez-Juanatey, Michel Komajda, Jose Lopez-Sendon, Jan-Christian Reil, Karl Swedberg, Luigi Tavazzi
Clinical research in cardiology : official journal of the German Cardiac Society - 2013
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial
(PARADIGM-HF)

J. J. McMurray, M. Packer, A. S. Desai, J. Gong, M. P. Lefkowitz, A. R. Rizkala, J. Rouleau, V. C. Shi, S. D. Solomon, Karl Swedberg, M. R. Zile
European Journal of Heart Failure - 2013
The Prognostic Significance of Heart Rate in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction in Sinus Rhythm. Insights From the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan)
Trial

S. J. Greene, M. Vaduganathan, J. E. Wilcox, M. E. Harinstein, A. P. Maggioni, H. Subacius, F. Zannad, M. A. Konstam, O. Chioncel, C. W. Yancy, Karl Swedberg, J. Butler, R. O. Bonow, M. Gheorghiade
JACC: Heart Failure - 2013
Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: insights from the SHIFT
study

L. Tavazzi, Karl Swedberg, M. Komajda, M. Bohm, J. S. Borer, M. Lainscak, I. Ford
European Journal of Heart Failure - 2013
Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT
trials

K. Fox, M. Komajda, I. Ford, M. Robertson, M. Bohm, J. S. Borer, P. G. Steg, L. Tavazzi, M. Tendera, R. Ferrari, Karl Swedberg
European Heart Journal - 2013
Do Countries or Hospitals With Longer Hospital Stays for Acute Heart Failure Have Lower Readmission Rates?: Findings From
ASCEND-HF

Z. J. Eapen, S. D. Reed, Y. Li, R. D. Kociol, P. W. Armstrong, R. C. Starling, J. J. McMurray, B. M. Massie, Karl Swedberg, J. A. Ezekowitz, G. C. Fonarow, J. R. Teerlink, M. Metra, D. J. Whellan, C. M. O'Connor, R. M. Califf, A. F. Hernandez
Circulation Heart Failure - 2013
Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST
trial

N. Girerd, P. S. Pang, Karl Swedberg, A. Fought, M. J. Kwasny, H. Subacius, M. A. Konstam, A. Maggioni, M. Gheorghiade, F. Zannad
European Journal of Heart Failure - 2013
Association of low body temperature and poor outcomes in patients admitted with worsening heart failure: a substudy of the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST)
trial

S. Payvar, J. A. Spertus, A. B. Miller, S. W. Casscells, P. S. Pang, F. Zannad, Karl Swedberg, A. P. Maggioni, K. J. Reid, M. Gheorghiade
European Journal of Heart Failure - 2013
Guidelines for the treatment of valvular heart disease (version 2012). Joint task force for the treatment of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardiothoracic Surgery
(EACTS)

A. Vahanian, O. Alfieri, F. Andreotti, M. J. Antunes, G. Baron-Esquivias, H. Baumgartner, M. A. Borger, T. P. Carrel, M. De Bonis, A. Evangelista, V. Falk, B. Iung, P. Lancellotti, L. Pierard, S. Price, H. J. Schafers, G. Schuler, J. Stepinska, Karl Swedberg, J. Takkenberg, U. O. Von Oppell, S. Windecker, J. L. Zamorano, M. Zembala
Giornale Italiano di Cardiologia - 2013
Clinical characteristics and outcomes of young and very young adults with heart failure: the CHARM
programme

C. M. Wong, N. M. Hawkins, P. S. Jhund, M. Macdonald, S. D. Solomon, C. B. Granger, S. Yusuf, M. A. Pfeffer, Karl Swedberg, M. C. Petrie, J. J. McMurray
Journal of the American College of Cardiology - 2013
Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: An efficacy and safety analysis of SHIFT
study

L. Tavazzi, Karl Swedberg, M. Komajda, M. Bohm, J. S. Borer, M. Lainscak, M. Robertson, I. Ford
International Journal of Cardiology - 2013
Impact of left bundle branch block on heart rate and its relationship to treatment with ivabradine in chronic heart
failure

J. C. Reil, M. Robertson, I. Ford, J. Borer, M. Komajda, Karl Swedberg, L. Tavazzi, M. Bohm
European Journal of Heart Failure - 2013
Clinical Benefit of Eplerenone in Patients With Mild Symptoms of Systolic Heart Failure Already Receiving Optimal Best Practice Background Drug Therapy: Analysis of the EMPHASIS-HF
Study

H. Krum, H. Shi, B. Pitt, J. McMurray, Karl Swedberg, D. J. van Veldhuisen, J. Vincent, S. Pocock, F. Zannad
Circulation Heart Failure - 2013
Safety and efficacy of eplerenone in patients at high-risk for hyperkalemia and/or worsening renal function: Analyses of EMPHASIS-HF study
subgroups

R. Eschalier, J. J. McMurray, Karl Swedberg, D. J. van Veldhuisen, H. Krum, S. J. Pocock, H. Shi, J. Vincent, P. Rossignol, F. Zannad, B. Pitt
Journal of the American College of Cardiology - 2013
Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus
document

F. Zannad, A. A. Garcia, S. D. Anker, P. W. Armstrong, G. Calvo, J. G. Cleland, J. N. Cohn, K. Dickstein, M. J. Domanski, Inger Ekman, G. S. Filippatos, M. Gheorghiade, A. F. Hernandez, T. Jaarsma, J. Koglin, M. Konstam, S. Kupfer, A. P. Maggioni, A. Mebazaa, M. Metra, C. Nowack, B. Pieske, I. L. Pina, S. J. Pocock, P. Ponikowski, G. Rosano, L. M. Ruilope, F. Ruschitzka, T. Severin, S. Solomon, K. Stein, N. L. Stockbridge, W. G. Stough, Karl Swedberg, L. Tavazzi, A. A. Voors, S. M. Wasserman, H. Woehrle, A. Zalewski, J. J. McMurray
European Journal of Heart Failure - 2013
Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure
patients

J. C. Reil, J. C. Tardif, I. Ford, S. M. Lloyd, E. O'Meara, M. Komajda, J. S. Borer, L. Tavazzi, Karl Swedberg, M. Bohm
Journal of the American College of Cardiology - 2013
Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST
trial

D. E. Lanfear, H. N. Sabbah, S. R. Goldsmith, S. J. Greene, A. P. Ambrosy, A. J. Fought, M. J. Kwasny, Karl Swedberg, C. W. Yancy, M. A. Konstam, A. P. Maggioni, F. Zannad, M. Gheorghiade
Circulation Heart Failure - 2013
Trends in mortality after first hospitalization with Atrial Fibrillation diagnosis in Sweden 1987 to
2006

Lars G. Olsson, Karl Swedberg, Georg Lappas, S. Stewart, Annika Rosengren
International Journal of Cardiology - 2013
Person-centred care inluences the belief in medication in patients with chronic heart
failure

Kerstin Dudas, Lars-Eric Olsson, Karl Swedberg, Axel Wolf, Inger Ekman
European Journal of Heart Failure. - 2013
PCC- Impact at admission and discharge process, among patients with chronic heart
failure

Kerstin Dudas, Lars-Eric Olsson, Axel Wolf, Karl Swedberg, Charles Taft, Inger Ekman
European Journal of Cardiovascular Nursing - 2013
Risk following hospitalization in stable chronic systolic heart
failure

Putte Abrahamsson, Karl Swedberg, J. S. Borer, M. Bohm, L. Kober, M. Komajda, S. M. Lloyd, M. Metra, L. Tavazzi, I. Ford
European Journal of Heart Failure - 2013
The past, present and future of renin-angiotensin aldosterone system
inhibition

R. J. Mentz, G. L. Bakris, B. Waeber, J. J. McMurray, M. Gheorghiade, L. M. Ruilope, A. P. Maggioni, Karl Swedberg, I. L. Pina, M. Fiuzat, C. M. O'Connor, F. Zannad, B. Pitt
International journal of cardiology - 2013
Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST)
trial

A. P. Ambrosy, M. Vaduganathan, R. J. Mentz, S. J. Greene, H. Subacius, M. A. Konstam, A. P. Maggioni, Karl Swedberg, M. Gheorghiade
American Heart Journal - 2013
Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial
(RED-HF)

J. J. McMurray, I. S. Anand, R. Diaz, A. P. Maggioni, C. O'Connor, M. A. Pfeffer, S. D. Solomon, M. Tendera, D. J. van Veldhuisen, M. Albizem, S. Cheng, D. Scarlata, Karl Swedberg, J. B. Young
European Journal of Heart Failure - 2013
Treatment of Anemia with Darbepoetin Alfa in Systolic Heart
Failure

Karl Swedberg, J. B. Young, I. S. Anand, S. Cheng, A. S. Desai, R. Diaz, A. P. Maggioni, J. J. McMurray, C. O'Connor, M. A. Pfeffer, S. D. Solomon, Y. Sun, M. Tendera, D. J. van Veldhuisen
New England Journal of Medicine - 2013
Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST
trial

A. P. Ambrosy, P. S. Pang, S. Khan, M. A. Konstam, G. C. Fonarow, B. Traver, A. P. Maggioni, T. Cook, Karl Swedberg, J. C., Jr. Burnett, L. Grinfeld, J. E. Udelson, F. Zannad, M. Gheorghiade
European Heart Journal - 2013
Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST
trial

R. J. Mentz, B. D. Allen, M. J. Kwasny, M. A. Konstam, J. E. Udelson, A. P. Ambrosy, A. J. Fought, M. Vaduganathan, C. M. O'Connor, F. Zannad, A. P. Maggioni, Karl Swedberg, R. O. Bonow, M. Gheorghiade
European journal of heart failure - 2013
Relationship Between Clinical Trial Site Enrollment With Participant Characteristics, Protocol Completion, and Outcomes Insights From the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan)
Trial

J. Butler, H. Subacius, M. Vaduganathan, G. C. Fonarow, A. P. Ambrosy, M. A. Konstam, A. Maggioni, R. J. Mentz, Karl Swedberg, F. Zannad, M. Gheorghiade
Journal of the American College of Cardiology - 2013
Patients with worsening chronic heart failure who present to a hospital emergency department require hospital
care.

Masoud Shafazand, Harshida Patel, Inger Ekman, Karl Swedberg, Maria Schaufelberger
BMC research notes - 2012
The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data
meta-analysis.

C Berry, R.N. Doughty, C Granger, L Kober, B Massie, F McAlister, J McMurray, S Pocock, K Poppe, Karl Swedberg, Bert Andersson
European heart journal - 2012
Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient
meta-analysis

M. Martinez-Selles, R. N. Doughty, K. Poppe, G. A. Whalley, N. Earle, C. Tribouilloy, J. J. McMurray, Karl Swedberg, L. Kober, C. Berry, I. Squire, Bert Andersson
European journal of heart failure - 2012
Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery
(EACTS)

A. Vahanian, O. Alfieri, F. Andreotti, M. J. Antunes, G. Baron-Esquivias, H. Baumgartner, M. A. Borger, T. P. Carrel, M. De Bonis, A. Evangelista, V. Falk, B. Iung, P. Lancellotti, L. Pierard, S. Price, H. J. Schafers, G. Schuler, J. Stepinska, Karl Swedberg, J. Takkenberg, U. O. Von Oppell, S. Windecker, J. L. Zamorano, M. Zembala, J. J. Bax, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoes, P. Kirchhof, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, M. Tendera, A. Torbicki, L. Von Segesser, L. P. Badano, M. Bunc, M. J. Claeys, N. Drinkovic, G. Filippatos, G. Habib, A. P. Kappetein, R. Kassab, G. Y. Lip, N. Moat, G. Nickenig, C. M. Otto, J. Pepper, N. Piazza, P. G. Pieper, R. Rosenhek, N. Shuka, E. Schwammenthal, J. Schwitter, P. T. Mas, P. T. Trindade, T. Walther
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery - 2012
Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal
impairment

M. Vaduganathan, M. Gheorghiade, P. S. Pang, M. A. Konstam, F. Zannad, Karl Swedberg, L. Grinfeld, J. C. Burnett, H. B. Krasa, C. Zimmer, J. Blair, J. Ouyang, A. P. Maggioni
Journal of Cardiovascular Medicine - 2012
Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST
trial

A. P. Ambrosy, M. Vaduganathan, M. D. Huffman, S. Khan,